Cargando…
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
Compared with conventional cancer therapies, the spectrum of toxicities observed with checkpoint inhibitors is unique and can affect any organ system. Arthralgia and myalgia were by far the most commonly reported rheumatic immune-related adverse events in clinical trials, and there is now a growing...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900916/ https://www.ncbi.nlm.nih.gov/pubmed/31816082 http://dx.doi.org/10.1093/rheumatology/kez295 |